Ultralife Corp - ULBI - reported that it has received a contract to supply 2,319 of its A-320 amplifier systems to a major international defense contractor. On its third quarter fiscal 2012, Virtusa Corp - VRTU - posted revenue of $72.2 million, an increase of 3% sequentially and 30% year-over-year. Furiex Pharmaceuticals Inc - FURX - reported that the European Commission endorsed the positive opinion adopted by the Committee for Human Medicinal Products on October 18, 2011 for Priligy (dapoxetine) 30 and 60 mg doses. ********************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)
投稿者: karmastock
投稿日時:2012-02-01 09:44:04.0
視聴回数:439回
お気に入り登録:0
カテゴリ:
ビジネス全般
タグ:
ULBI
VRTU
FURX
Nasdaq:FURX
Nasdaq:VRTU
Nasdaq:ULBI